Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response-Reference-Cited by-同舟云学术

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Published:2019-10-31 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Baettig Florence,Vlajnic Tatjana,Vetter Marcus,Glatz Katharina,Hench Jürgen,Frank Stephan,Bihl Michel,Lopez Roberto,Dobbie Michael,Heinzelmann-Schwarz Viola,Montavon Céline^ORCID

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0742-6.pdf

Reference25 articles.

1. Heong V, Ngoi N, Tan DSP. Update on immune checkpoint inhibitors in gynecological cancers. J Gynecol Oncol. 2017;28(2):e20.

2. Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–71.

3. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(28):4649–55.

4. Minion LE, Tewari KS. Cervical cancer - state of the science: from angiogenesis blockade to checkpoint inhibition. Gynecol Oncol. 2018;148(3):609–21.

5. Tewari KS, Sill MW, Long HJ, 3rd, Penson RT, Huang H, Ramondetta LM, et al. Improved survival with bevacizumab in advanced cervical cancer. The New England journal of medicine. 2014;370(8):734-43.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer;Diseases;2024-04-15

2. EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics;Acta Neuropathologica Communications;2024-04-04

3. CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor;Journal of Cancer;2024

4. Current treatment options and limitations for cervical cancer;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

5. Study of Quercetin on Proliferation, Migration, Apoptosis and Autophagy of Sorafenib-Resistant Hela Cells;Advances in Clinical Medicine;2024